This study is about a medicine called maridebart cafraglutide, which is being tested to see how well it helps control blood sugar in adults with Type 2 Diabetes Mellitus (T2DM). People who join this study will be either given maridebart cafraglutide or a placebo, a substance that has no treatment effect, to compare how well the medicine works. To take part, you must be 18 years or older and have had Type 2 diabetes for at least six months. You should also have a specific range of blood sugar levels (HbA1c of 7.0% to 10.5%) and be managing your diabetes with diet, exercise, or certain medicines. However, if you have Type 1 diabetes, certain health conditions, or used specific diabetes medications recently, you might not be eligible.
- This study involves taking medication for blood sugar management.
- Participation requires regular health check-ups.
- Discuss potential risks and benefits with a doctor before joining.
How understandable was the trial content above?
Hard to understand
Easy to understand